NAMI Policy Research Institute Learn more about NAMI's Policy Research Institute, whose mission is to drive national, state, and local debates on reforms and investments in the nation's mental illness delivery and financing system.
NAMI Position on Medicare Conference Report The new benefits for prescription drug coverage and protections for vulnerable, low-income beneficiaries (including those dually eligible for both Medicare and Medicaid) appear to be a major improvement over the status quo and previous congressional proposals. As a result, NAMI has sent a letter to House and Senate leaders urging members to vote in favor of passage later this week.
The New Medicare Drug Plan and Beneficiaries with Mental Illness On December 8, 2003, President Bush signed into law the Medicare Modernization Act - a new law expanding the Medicare program to offer coverage for outpatient prescription drugs. While few of the new law's provisions apply solely to Medicare beneficiaries living with mental illness, the expanded coverage includes many changes that will impact the way Medicare is able to pay for mental illness treatment. This document contains commonly asked questions and answers about the how the new law will affect beneficiaries with mental illness (both elderly and non-elderly Social Security Disability Insurance (SSDI) beneficiaries).